QIAGEN Receives U.S. Department of Defense Contract to Further Expand Production Capacity for NeuMoDxBusiness Wire • 09/30/21
QIAGEN Reaches Milestone With Its Kits Used to Process More Than Three Billion Biological Samples to DateBusiness Wire • 08/23/21
QIAGEN and GT Molecular Collaborate to Offer a Complete SARS-CoV-2 Wastewater Detection Solution Based on QIAcuity Digital PCR TechnologyBusiness Wire • 08/10/21
Qiagen Inks Companion Diagnostic Development, Technology-Licensing Deal With OncXernaBenzinga • 08/10/21
QIAGEN and OncXerna Therapeutics Sign Licensing and Master Companion Diagnostic AgreementsBusiness Wire • 08/09/21
QIAGEN receives U.S. FDA emergency use authorization for rapid portable test that can analyze over 30 samples per hour for SARS-CoV-2 antigenBusiness Wire • 08/06/21
Qiagen (QGEN) Earnings Expected to Grow: What to Know Ahead of Next Week's ReleaseZacks Investment Research • 07/22/21
Qiagen Stock Drops After Trimming FY21 Earnings Forecast On Weaker COVID-19 Testing TrendsBenzinga • 07/12/21
QIAGEN N.V. Conference Call on July 13 to Discuss Preliminary Q2 2021 ResultsBusiness Wire • 07/12/21
QIAGEN announces preliminary Q2 2021 results exceeding outlook, updates full-year 2021 outlook for declining COVID-19 test trends and plans new $100 million share repurchase programBusiness Wire • 07/12/21
QIAGEN's NeuMoDx™ HAdV Quant Assay Secures CE-IVD Certification for Automated Testing to Detect Human Adenovirus InfectionsBusiness Wire • 07/08/21
QIAGEN launches the Workflow Configurator to help life science researchers simplify and optimize their laboratory experimentsBusiness Wire • 07/07/21